CELLUJUVE
LIVE

Serial Number

90377657

Owner

SPIDERWORT BIOTECHNOLOGIES INC.

Attorney

R. Scott Keller

First Use Date

Feb 22, 2023

Filing Date

Dec 12, 2020

Add to watchlist:

No watchlists yet
View on USPTO

CELLUJUVE Trademark

Serial Number: 90377657 • Registration: 7204278

CELLUJUVE is a trademark filed by SPIDERWORT BIOTECHNOLOGIES INC. on December 12, 2020. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently registered and active.

Owner Contact Info

SPIDERWORT BIOTECHNOLOGIES INC. (8 trademarks)

7 BAYVIEW STATION RD.
OTTAWA K1Y2C5 , CA

Entity Type: 03

Spiderwort Inc. (8 trademarks)

7 Bayview Station Rd
Ottawa, Ontario K1Y2C5 , CA

Entity Type: 03

Trademark Details

Filing Date

December 12, 2020

Registration Date

October 31, 2023

First Use Anywhere

February 22, 2023

First Use in Commerce

February 22, 2023

Published for Opposition

August 15, 2023

Goods & Services

Injectable dermal filler consisting of biological materials; injectable dermal filler consisting of artificial materials

Filing History

AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Feb 24, 2025 ASGN
NOTICE OF REGISTRATION CONFIRMATION EMAILED
Oct 31, 2023 NRCC
REGISTERED-PRINCIPAL REGISTER
Oct 31, 2023 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Aug 15, 2023 NPUB
PUBLISHED FOR OPPOSITION
Aug 15, 2023 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jul 26, 2023 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Jul 12, 2023 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Jul 12, 2023 TEME
NOTICE OF ACCEPTANCE OF AMENDMENT TO ALLEGE USE E-MAILED
May 20, 2023 AAUA
CORRESPONDENCE RECEIVED IN LAW OFFICE
May 19, 2023 CRFA
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
May 19, 2023 ERSI
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
May 19, 2023 GNS3
LETTER OF SUSPENSION E-MAILED
May 19, 2023 GNSL
SUSPENSION LETTER WRITTEN
May 19, 2023 CNSL
USE AMENDMENT ACCEPTED
May 19, 2023 IUAA
AMENDMENT TO USE PROCESSING COMPLETE
Apr 22, 2023 AUPC
USE AMENDMENT FILED
Apr 22, 2023 IUAF
TEAS AMENDMENT OF USE RECEIVED
Apr 21, 2023 EAAU
ASSIGNED TO EXAMINER
Mar 1, 2023 DOCK
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Dec 9, 2022 GNS3
LETTER OF SUSPENSION E-MAILED
Dec 9, 2022 GNSL
SUSPENSION LETTER WRITTEN
Dec 9, 2022 CNSL
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Dec 9, 2022 GNS3
LETTER OF SUSPENSION E-MAILED
Dec 9, 2022 GNSL
SUSPENSION LETTER WRITTEN
Dec 9, 2022 CNSL
TEAS/EMAIL CORRESPONDENCE ENTERED
Dec 7, 2022 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Dec 7, 2022 CRFA
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Dec 7, 2022 ERSI
NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
Jul 29, 2022 GNS2
INQUIRY TO SUSPENSION E-MAILED
Jul 29, 2022 GNSI
SUSPENSION INQUIRY WRITTEN
Jul 29, 2022 CNSI
NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
Jul 29, 2022 GNS2
INQUIRY TO SUSPENSION E-MAILED
Jul 29, 2022 GNSI
SUSPENSION INQUIRY WRITTEN
Jul 29, 2022 CNSI
TEAS/EMAIL CORRESPONDENCE ENTERED
Jul 8, 2022 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jul 8, 2022 CRFA
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Jul 8, 2022 ERSI
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Mar 13, 2022 GNS3
LETTER OF SUSPENSION E-MAILED
Mar 13, 2022 GNSL
SUSPENSION LETTER WRITTEN
Mar 13, 2022 CNSL
TEAS/EMAIL CORRESPONDENCE ENTERED
Feb 14, 2022 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Feb 13, 2022 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Feb 13, 2022 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Aug 16, 2021 GNRN
NON-FINAL ACTION E-MAILED
Aug 16, 2021 GNRT
NON-FINAL ACTION WRITTEN
Aug 16, 2021 CNRT
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Jun 4, 2021 GNRN
NON-FINAL ACTION E-MAILED
Jun 4, 2021 GNRT
NON-FINAL ACTION WRITTEN
Jun 4, 2021 CNRT
ASSIGNED TO EXAMINER
Jun 4, 2021 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Feb 20, 2021 NWOS
NEW APPLICATION ENTERED
Dec 16, 2020 NWAP